The meetings brought together regulators, policymakers, pharmaceutical industry representatives and international partners to accelerate regulatory cooperation and improve access to safe, effective and quality-assured medical products across the continent.
The proposed funding will support the Uganda AIDS Commission in coordinating prevention activities and expanding public awareness campaigns across the country.
The procedures involved Targeted Sensory Reinnervation (TSR), a technique that redirects sensory nerves to help amputees regain sensation through prosthetic limbs.
Led through the Medical AI Data for All (MAIDA) initiative at Harvard Medical School, the study explored ways to adapt existing AI technologies to neonatal care without requiring hospitals to share patient imaging data centrally.
The proposed investment will establish an intravenous (IV) fluids manufacturing facility in Barbados, with an initial annual production capacity of 12 million units and scope for future expansion.
The proposed collaboration covers laboratory infrastructure, workflow integration, training for clinical and laboratory teams, and the validation and regulatory requirements for potential deployment.
The recognised facilities are Magrabi Health Eye in North Jeddah, Eye and Dental in Makkah, and Magrabi Health Eye and Ear on Madina Road in Jeddah.
By reducing registration barriers, NAFDAC aims to encourage more small manufacturers to formalise their operations and bring products into the regulated market.
Held under the theme “Better Data, Better Health for All,” the Forum brings together governments, health experts, development partners, academic institutions, civil society and private sector representatives.
The Ministry will now observe a 42-day period without new infections before formally declaring the outbreak over.